(Q34604578)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11958802%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

review article

1 reference

title

Pathological haemostasis and "prothrombotic state" in Behçet's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11958802%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

0 references

Ibrahim Celalettin Haznedaroglu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11958802%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Ismail Celik

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11958802%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

author name string

Sedat Kiraz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11958802%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Ihsan Ertenli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11958802%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

M Akif Oztürk

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11958802%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Meral Calgüneri

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11958802%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11958802%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

number of pages

9

1 reference

inferred from page(s)

published in

Thrombosis Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11958802%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

105

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11958802%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11958802%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

125-133

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11958802%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Haemostasis, thrombosis, and endothelium in Behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Gastrointestinal manifestations of Behcet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Intracranial hypertension in Behçet's disease: demonstration of sinus occlusion with use of digital subtraction angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Intracardiac thrombus in Behçet's disease: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Pathologic features of Behçet's syndrome: a review of Japanese autopsy registry data

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Behcet's syndrome associated with minimal change glomerulonephritis and renal vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Acute myocardial infarction and recurrent ventricular arrhythmias in Behcet's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

1 reference

7 January 2021

Fibrin clot formation and lysis: basic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

The endothelium and thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Protein S deficiency and antibodies to protein S in patients with Behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Antithrombin III, protein C and protein S plasma levels in patients with Behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Protein C and protein S activities in Behçet's disease as risk factors of thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Comparison of coagulation parameters for healthy subjects and Behçet disease patients with and without vascular involvement.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Haemostatic markers of procoagulant imbalance in Behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Activated protein C resistance due to a common factor V gene mutation is a major risk factor for venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Coagulation factor V gene mutation increases the risk of venous thrombosis in behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Activated protein C resistance caused by factor V Arg 506-->Gln mutation has no role in thrombotic manifestations of Behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Activated protein C resistance in Behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

The prothrombin 20210 G to A variation and thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Procoagulant mutations and venous thrombosis in Behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Hyperhomocysteinaemia and activated protein C resistance in Behçet's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Impaired haemostatic kinetics and endothelial function in Behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Heparin induces release of extrinsic: Coagulation pathway inhibitor (EPI)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Changes in the concentration and distribution of tissue factor pathway inhibitor in Behçet's disease and systemic lupus erythematosus: effect on the prethrombotic state

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Anticardiolipin antibodies in Adamantiades-Behçet's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Anticardiolipin antibodies: occurrence in Behçet's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Anticardiolipin antibodies in Behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Thrombolytic therapy in pulmonary embolism of Behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Plasminogen activator activity levels in patients with Behçet's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Antibodies to endothelial cells in patients with Behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Antibodies to endothelial cells in Behçet's disease: cell-binding heterogeneity and association with clinical activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Plasma von Willebrand factor, tissue plasminogen activator, plasminogen activator inhibitor, and antithrombin III levels in Behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Selectin adhesion molecules in Behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Plasma prostacyclin levels in Behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Eicosanoids in the prethrombotic state of Behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Vascular endothelial function and oxidative stress mechanisms in patients with Behçet's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Nitric oxide and inflammatory joint diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

1 reference

7 January 2021

Kinetics of the inhibition of thrombin by hirudin.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Highly selective tripeptide thrombin inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

A peptide derived from a tissue factor loop region functions as a tissue factor-factor VIIa antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Synthetic peptide analogs of tissue factor and factor VII which inhibit factor Xa formation by the tissue factor/factor VIIa complex

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Influence of Blockade at Specific Levels of the Coagulation Cascade on Restenosis in a Rabbit Atherosclerotic Femoral Artery Injury Model

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Ancylostoma caninum anticoagulant peptide: a hookworm-derived inhibitor of human coagulation factor Xa.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Recombinant human protein C derivatives: altered response to calcium resulting in enhanced activation by thrombin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Enhanced protein C activation and inhibition of fibrinogen cleavage by a thrombin modulator

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Evidence that prostaglandin endoperoxides can induce platelet aggregation in the absence of thromboxane A2 production

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Prevention of restenosis after percutaneous transluminal coronary angioplasty with thromboxane A2-receptor blockade. A randomized, double-blind, placebo-controlled trial. Coronary Artery Restenosis Prevention on Repeated Thromboxane-Antagonism Study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

Randomized trial of ridogrel, a combined thromboxane A2 synthase inhibitor and thromboxane A2/prostaglandin endoperoxide receptor antagonist, versus aspirin as adjunct to thrombolysis in patients with acute myocardial infarction. The Ridogrel Versus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900006-3

7 January 2021

10.1016/S0049-3848(02)00006-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11958802%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference